Published in J Biol Inorg Chem on April 19, 2014
Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment. BBA Clin (2016) 0.78
Zinc in the Glutamatergic Theory of Depression. Curr Neuropharmacol (2015) 0.77
The serum zinc concentration as a potential biological marker in patients with major depressive disorder. Metab Brain Dis (2016) 0.75
Alterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in Rats. Neurotox Res (2015) 0.75
Zinc Prevents the Development of Diabetic Cardiomyopathy in db/db Mice. Int J Mol Sci (2017) 0.75
Zinc and Oxidative Stress: Current Mechanisms. Antioxidants (Basel) (2017) 0.75
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
The biochemical basis of zinc physiology. Physiol Rev (1993) 6.59
Diagnosis and treatment of Wilson disease: an update. Hepatology (2008) 4.79
Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes (2004) 4.25
Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr (2006) 3.09
ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A (1996) 3.06
Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet (1996) 2.95
Transition metals in control of gene expression. Science (1993) 2.90
Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci U S A (1999) 2.50
Zinc and brain injury. Annu Rev Neurosci (1998) 2.43
A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet (2002) 2.41
Blood lead and blood pressure. Relationship in the adolescent and adult US population. JAMA (1985) 2.33
Human zinc deficiency. J Nutr (2000) 2.32
Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet (2002) 2.29
Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology (2009) 2.25
Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr (2000) 2.16
The essential toxin: impact of zinc on human health. Int J Environ Res Public Health (2010) 2.09
Zinc and human health: an update. Arch Toxicol (2011) 2.08
Zinc homeostasis in humans. J Nutr (2000) 2.03
Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey. Proc Natl Acad Sci U S A (1997) 1.89
Zinc, insulin and diabetes. J Am Coll Nutr (1998) 1.89
Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother (2003) 1.79
Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci (2010) 1.74
Wilson disease. Best Pract Res Clin Gastroenterol (2010) 1.71
Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A (2002) 1.68
Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem (2001) 1.64
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem (2000) 1.60
Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients. Am J Gastroenterol (1999) 1.58
Antioxidant effect of zinc in humans. Free Radic Biol Med (2004) 1.56
Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr (1991) 1.54
Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev (2000) 1.48
Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist (2004) 1.46
Zinc: a multipurpose trace element. Arch Toxicol (2005) 1.45
Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr (2009) 1.44
Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res (2003) 1.42
Oral zinc therapy for Wilson's disease. Ann Intern Med (1983) 1.37
Zinc deficiency. BMJ (2003) 1.33
Metallothioneins: new functional and structural insights. Curr Opin Chem Biol (2000) 1.32
Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr (2001) 1.29
Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1. J Biol Chem (2012) 1.24
Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals (2002) 1.19
Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr (2012) 1.14
Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr (2010) 1.12
Zinc and disease of the brain. Mol Neurobiol (2002) 1.12
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis (2010) 1.11
Essential role of vitamin C and zinc in child immunity and health. J Int Med Res (2010) 1.10
Zinc binding, circular dichroism, and equilibrium sedimentation studies on insulin (bovine) and several of its derivatives. Biochemistry (1974) 1.09
Hypozincemia in depression. J Affect Disord (1994) 1.08
Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr (1998) 1.07
Zinc and diabetes mellitus: is there a need of zinc supplementation in diabetes mellitus patients? Biol Trace Elem Res (2001) 1.06
Developmental zinc deficiency and behavior. J Nutr (1995) 1.06
Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms. Brain Res (2008) 1.06
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity. J Neurochem (2011) 1.06
Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav (2008) 1.05
Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol (2012) 1.04
Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol Lett (1998) 1.03
Zinc and cardiovascular disease. Nutrition (2010) 1.02
Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids (2008) 1.02
Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol Heart Circ Physiol (2009) 1.02
Zinc. J Toxicol Clin Toxicol (1999) 1.00
Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet (2000) 1.00
Decreased brain zinc availability reduces hippocampal neurogenesis in mice and rats. J Cereb Blood Flow Metab (2009) 0.99
Zinc in depressive disorder. Acta Psychiatr Scand (1990) 0.99
Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals (2009) 0.98
Zinc homeostasis in the metabolic syndrome and diabetes. Front Med (2013) 0.98
Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease. Biofactors (2012) 0.98
Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res (2009) 0.97
Glycemic control of type 2 diabetic patients after short-term zinc supplementation. Nutr Res Pract (2008) 0.97
Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex. Protein Sci (1996) 0.97
Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. Am J Alzheimers Dis Other Demen (2010) 0.96
The oxidative stress of zinc deficiency. Metallomics (2011) 0.96
Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspase-dependent and -independent signaling pathways. Neurotox Res (2009) 0.93
Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J Cell Biol (1997) 0.93
Zinc restriction during different periods of life: influence in renal and cardiovascular diseases. Nutrition (2010) 0.93
Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. J Alzheimers Dis (2003) 0.92
Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord (2010) 0.92
Is zinc deficiency a public health problem? Nutrition (1995) 0.91
Association of zinc deficiency and depression in the patients with end-stage renal disease on hemodialysis. J Ren Nutr (2010) 0.91
Role of zinc in regulation of arterial blood pressure and in the etiopathogenesis of arterial hypertension. Biol Trace Elem Res (2007) 0.90
Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep (2006) 0.90
The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.89
Zinc and depression. An update. Pharmacol Rep (2005) 0.88
Role of zinc supplementation in type II diabetes mellitus. Am J Med (1986) 0.88
Treatment of burns with zinc-tape. A study of local absorption of zinc in humans. Scand J Plast Reconstr Surg (1977) 0.88
Alzheimer's disease, beta-amyloid protein and zinc. J Nutr (2000) 0.87
Effect of zinc on the lipid peroxidation and the antioxidant defense systems of the alloxan-induced diabetic rabbits. Free Radic Biol Med (2007) 0.87
Zinc supplementation or regulation of its homeostasis: advantages and threats. Biol Trace Elem Res (2007) 0.86
Disruption of the CaMKII/CREB signaling is associated with zinc deficiency-induced learning and memory impairments. Neurotox Res (2010) 0.85
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacol Rep (2012) 0.84
Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week zinc deprivation. Neurochem Int (2009) 0.84
Zinc may be a mediator of leptin production in humans. Life Sci (2000) 0.83
Levels of copper and zinc in depression. Indian J Physiol Pharmacol (1991) 0.83
Zinc signaling in the hippocampus and its relation to pathogenesis of depression. Mol Neurobiol (2010) 0.82
Zinc, insulin, and the liver: a ménage à trois. J Clin Invest (2013) 0.82
Zinc modulates PPARgamma signaling and activation of porcine endothelial cells. J Nutr (2003) 0.82
The role of the GPR39 receptor in zinc deficient-animal model of depression. Behav Brain Res (2012) 0.82
Zinc balance and medications commonly used in the management of heart failure. Heart Fail Rev (2006) 0.81
Prenatal zinc deficiency: influence on heart morphology and distribution of key heart proteins in a rat model. Biol Trace Elem Res (2008) 0.81
The zinc transporter Zip5 (Slc39a5) regulates intestinal zinc excretion and protects the pancreas against zinc toxicity. PLoS One (2013) 0.81
Investigational NMDA receptor modulators for depression. Expert Opin Investig Drugs (2011) 1.45
Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol (2007) 1.22
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology (2012) 1.06
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord (2009) 1.05
NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav (2007) 1.01
Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology (Berl) (2008) 1.01
Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pharmacol Biochem Behav (2005) 0.99
Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Neuropharmacology (2004) 0.99
GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs Today (Barc) (2005) 0.99
A search for genes modulated by interleukin-6 alone or with interleukin-1beta in HepG2 cells using differential display analysis. Biochim Biophys Acta (2005) 0.98
Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull (2003) 0.96
The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. J Affect Disord (2011) 0.96
The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.96
Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm (Vienna) (2008) 0.94
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.92
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. J Pharmacol Exp Ther (2007) 0.92
Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord (2010) 0.92
Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep (2008) 0.92
A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice. J Neural Transm (Vienna) (2011) 0.91
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors. Eur J Med Chem (2012) 0.90
Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep (2006) 0.90
Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. Eur J Pharmacol (2004) 0.89
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors. J Pharmacol Exp Ther (2006) 0.89
The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.89
Simultaneous determination of buprenorphine and norbuprenorphine in serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry. J Anal Toxicol (2005) 0.89
Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine. Pharmacol Rep (2006) 0.88
Zinc and depression. An update. Pharmacol Rep (2005) 0.88
Identification of novel serotonin transporter compounds by virtual screening. J Chem Inf Model (2014) 0.86
Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior. Pharmacol Rep (2008) 0.86
Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity. Eur J Med Chem (2009) 0.85
NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice. Pharmacol Rep (2008) 0.85
Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacol Rep (2012) 0.85
Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav (2004) 0.85
Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol (2003) 0.85
Human Freud-2/CC2D1B: a novel repressor of postsynaptic serotonin-1A receptor expression. Biol Psychiatry (2009) 0.85
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacol Rep (2012) 0.84
Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. Pol J Pharmacol (2003) 0.84
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677. Cell Mol Neurobiol (2006) 0.84
GPR39 up-regulation after selective antidepressants. Neurochem Int (2013) 0.84
Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice. Pharmacol Biochem Behav (2005) 0.84
NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opin Investig Drugs (2014) 0.84
Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol Rep (2010) 0.83
Magnesium in depression. Pharmacol Rep (2013) 0.83
Effect of rutin on total antioxidant status of rats exposed to cigarette smoke. Pharmacol Rep (2005) 0.83
Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex. Amino Acids (2010) 0.82
[Application of cotinine determination for the assessment of active and passive smoking of delivering women]. Rocz Panstw Zakl Hig (2003) 0.82
Oxidative stress markers in affective disorders. Pharmacol Rep (2013) 0.82
The role of the GPR39 receptor in zinc deficient-animal model of depression. Behav Brain Res (2012) 0.82
The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids (2009) 0.82
NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice. Pharmacol Rep (2011) 0.82
Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J Affect Disord (2013) 0.82
Effect of MPEP treatment on brain-derived neurotrophic factor gene expression. Pharmacol Rep (2006) 0.81
Exposure to ethanol and tobacco smoke in relation to level of PCNA antigen expression in pancreatic and hepatic rat cells. Pharmacol Rep (2013) 0.81
Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. Pol J Pharmacol (2003) 0.81
D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacol Rep (2009) 0.81
Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol Rep (2011) 0.80
In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling. Neuropsychopharmacology (2004) 0.80
Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.80
Concentration of ethanol and other volatile compounds in the blood of acutely poisoned alcoholics. Alcohol (2002) 0.80
Pregabalin for the treatment of social anxiety disorder. Expert Opin Investig Drugs (2014) 0.80
Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with copper. Hum Psychopharmacol (2000) 0.79
Effect of pregnancy and tobacco smoke on the antioxidant activity of rutin in an animal model. Pharmacol Rep (2009) 0.79
Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1. Eur J Med Chem (2011) 0.79
Glial degeneration as a model of depression. Pharmacol Rep (2013) 0.79
Zinc as a marker of affective disorders. Pharmacol Rep (2013) 0.79
Increase in synaptic hippocampal zinc concentration following chronic but not acute zinc treatment in rats. Brain Res (2006) 0.79
Zinc deficiency alters responsiveness to antidepressant drugs in mice. Pharmacol Rep (2013) 0.79
Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacol Rep (2007) 0.79
Mechanisms contributing to antidepressant zinc actions. Pol J Pharmacol (2003) 0.78
Alterations in hippocampal calcium-binding neurons induced by stress models of depression: a preliminary assessment. Pharmacol Rep (2011) 0.78
Effects of South African traditional medicine in animal models for depression. J Ethnopharmacol (2008) 0.78
[Clinical condition of the newborn versus tobacco smoke exposure during fetal life]. Przegl Lek (2009) 0.78
Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus. Pol J Pharmacol (2004) 0.78
The impact of intrauterine tobacco exposure on the cerebral mass of the neonate based on the measurement of head circumference. Brain Behav (2012) 0.78
Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. Pharmacol Rep (2013) 0.78
Evaluation of oxidative status and depression-like responses in Brown Norway rats with acute myeloid leukemia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.78
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2. Eur J Med Chem (2009) 0.78
[Nicotine in the hair as a biomarker of tobacco smoke by pregnant women--preliminary study]. Przegl Lek (2007) 0.78
Effects of acute and chronic treatment with magnesium in the forced swim test in rats. Pharmacol Rep (2005) 0.78